BioV2alve deals with the development of biohybrid venous valves for minimal invasive treatment of chronic veneous insufficiency.
To improve life quality of lung cancer patients we develop biohybrid respiratory stent, PulmoStent.
The BioPacer project is developing a biological pacemaker for babies and children.Traditional pacemakers are too big for the chest.The "BioPacer" consists of a small cylinder that is populated with endogenous cells of the heart-sick child and cultivated in a bioreactor. It will treat heart rhythm disorders.
The E-Suture project is investigating the use of tension-optimising materials and yarn structures as surgical suture material.
We are developing a fully functional windpipe with capillary-like structures in the TracheaPrint project.
The FibroGraft project focuses on the use of naturally dissolved silk fibroins in materials technology and the creation of different fibroin composites for tissue engineering.
In the EndOxy project we are developing a biohybrid lung that enables patients with life-threatening lung failure to receive long-term lung support
In the CellSpray project, we are working on the application of an innovatice spraying process for local cell therapy of the lungs.
The aim of the Implant Monitoring project is to establish longitudinal monitoring of tissue maturation and to validate it in animal experiments. To this end, an understanding of the biological dynamics of the insertion and remodelling process of biohybrid cardiovascular implants will be gained using the example of the geometrically simple vascular prosthesis. In order to investigate the interactions between (i) biomaterial, (ii) cellular components and (iii) implant environment non-invasively, methods of hybrid MR-PET and molecular ultrasound imaging will be investigated and tested.
The project pHMed researchs solution spun PLA fibres with pH-neutral degradation characteristics